PCSK9 and cardiovascular disorder: Demonstrating effectiveness in studies addressing myocardial infarction (40) and hypercholesterolaemia (39), drugs that target PCSK9 hold substantial promise for treating atherosclerosis, hypercholesterolaemia, and other related cardiovascular diseases.